Muddying the waters? A false positive case of autoimmune psychosis.
Sarangan KetheesanGeorgia BertramRobert AdamAnne StarkJames G ScottPublished in: Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists (2020)
Psychiatrists should restrict screening for antineuronal antibodies in people with chronic psychosis to those with higher risk features such as persistent treatment refractory symptoms with concurrent neurological signs and symptoms. Further research informing the clinical circumstances for antineuronal antibody testing is needed.